NCT05743660

Brief Summary

The observational study aims to discover differentially expressed circRNAs in the peripheral blood of patients with postoperative delirium, which aims to answer the main questions at: Whether there are changes in circRNA expression in peripheral blood in elderly patients with delirium after cardiopulmonary bypass surgery? Whether the circRNA with altered expression plays an important role in the occurrence and development of POD? What are the functions and underlying mechanisms of circRNA with altered expression in POD? Voluntary patients will receive follow-up 1 day before and 7 days after surgery to assess their cognitive function, and peripheral blood will be collected 1 day before and 3 days after surgery. The study divided patients into POD group and non-POD group according to whether delirium occurred within 7 days after surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 30, 2022

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

February 14, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 24, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2023

Completed
Last Updated

March 7, 2023

Status Verified

February 1, 2023

Enrollment Period

11 months

First QC Date

February 14, 2023

Last Update Submit

March 4, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Differences in circRNA microarrays before and after surgery

    Plasma was isolated from peripheral blood, RNA samples were prepared, and circRNA microarray analysis was performed. The differences in circRNA expression in peripheral blood of POD patients and non-POD patients were comprehensively analyzed.

    1 day before surgery,3 day after surgery

  • 3-minute Diagnostic Interview for CAM

    Postoperative delirium was assessed by 3-minute Diagnostic Interview for confusion assessment method (CAM).

    Consecutive 7 days after the surgery

Study Arms (2)

POD group

According to the occurrence of postoperative delirium, the patients were divided into POD group and non-POD group

non-POD group

According to the occurrence of postoperative delirium, the patients were divided into POD group and non-POD group

Eligibility Criteria

Age50 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing heart surgery

You may qualify if:

  • Be over 50 years old;
  • ASA Grade I-III;
  • Heart surgery is planned under general anesthesia.

You may not qualify if:

  • Patients with the second surgery;
  • The ejection fraction is less than 40%;
  • The score of the preoperative simple mental status examination (MMSE) is less than 24 points;
  • Patients with mental illness or central nervous system disease;
  • Patients who cannot or refuse to complete MMSE before surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xuzhou Central Hospital

Xuzhou, Jiangsu, 221000, China

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Plasma is isolated from peripheral blood to extract plasma

MeSH Terms

Conditions

Emergence Delirium

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Study Officials

  • Yangzi Zhu, Doctor

    Xuzhou Central Hospital

    PRINCIPAL INVESTIGATOR
  • Liwei Wang, Doctor

    Xuzhou Central Hospital

    STUDY DIRECTOR

Central Study Contacts

Yangzi Zhu, Doctor

CONTACT

Liwei Wang, Doctor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 14, 2023

First Posted

February 24, 2023

Study Start

June 30, 2022

Primary Completion

May 30, 2023

Study Completion

September 30, 2023

Last Updated

March 7, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations